Loading...
Derniers dépôts
-
Angeline Ginzac, Ioana Molnar, Xavier Durando, Thibault de La Motte Rouge, Thierry Petit, et al.. Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial. Breast Cancer Research and Treatment, 2024, ⟨10.1007/s10549-024-07285-y⟩. ⟨hal-04495069⟩
-
Charlotte Demoor-Goldschmidt, Pascal Veillon, Maxime Esvan, Mathilde Leonard, Sophie Chauvet, et al.. A software tool to support follow-up care in a French childhood cancer cohort: construction and feasibility. BMC Cancer, 2024, Bmc Cancer, 24 (1), pp.130. ⟨10.1186/s12885-024-11857-y⟩. ⟨hal-04484217⟩
-
Enora Dolivet, Léopold Gaichies, Corinne Jeanne, Céline Bazille, Mélanie Briand, et al.. Synergy of the microRNA Ratio as a Promising Diagnosis Biomarker for Mucinous Borderline and Malignant Ovarian Tumors. International Journal of Molecular Sciences, 2023, International Journal of Molecular Sciences, 24 (21), pp.16016. ⟨10.3390/ijms242116016⟩. ⟨hal-04481385⟩
-
Asmaa Janah, Charlotte Demoor-Goldschmidt, Florent de Vathaire, Nicolas Bougas, Jacqueline Clavel, et al.. Risk perceptions and health care use in the era of the COVID-19 pandemic in adults treated for childhood cancer. Supportive Care in Cancer, 2022, 30 (7), pp.6263 - 6271. ⟨10.1007/s00520-022-07035-0⟩. ⟨inserm-04438518⟩
-
Samia Chaouni, Alexandre Leduc, Frédéric Pouzoulet, Ludovic de Marzi, Frédérique Megnin-Chanet, et al.. Biological Effects of Scattered Versus Scanned Proton Beams on Normal Tissues in Total Body Irradiated Mice: Survival, Genotoxicity, Oxidative Stress and Inflammation. Antioxidants , 2020, 9 (12), pp.1170. ⟨10.3390/antiox9121170⟩. ⟨hal-04151956⟩
-
Stéphane Culine, Valentin Harter, Gwenaelle Gravis, Aude Fléchon, Christine Chevreau, et al.. Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial. Clinical Genitourinary Cancer, 2021, 19 (6), pp.554-562. ⟨10.1016/j.clgc.2021.08.005⟩. ⟨hal-03625944⟩
-
Jennifer Le Guevelou, Colin Debaigt, Esma Saada-Bouzid, Julien Viotti, Nazim Khalladi, et al.. Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol.. BMJ Open, 2020, BMJ Open, 10, pp.e038391. ⟨10.1136/bmjopen-2020-038391⟩. ⟨hal-04346738⟩
-
Thomas Grinda, Alison Antoine, William Jacot, Paul-Henri Cottu, Thibault de la Motte Rouge, et al.. Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort. European Journal of Cancer, 2023, 189, pp.112935. ⟨10.1016/j.ejca.2023.05.023⟩. ⟨hal-04205902⟩
-
Lionel Falchero, Florian Guisier, Marie Darrason, Arnaud Boyer, Charles Dayen, et al.. Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world study. Lung Cancer, 2023, 185, ⟨10.1016/j.lungcan.2023.107379⟩. ⟨hal-04229547⟩
Nombre de documents
163
Nombre de notices
197